188 related articles for article (PubMed ID: 23063501)
1. Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway.
Wu F; Echeverry R; Wu J; An J; Haile WB; Cooper DS; Catano M; Yepes M
Mol Cell Neurosci; 2013 Jan; 52():9-19. PubMed ID: 23063501
[TBL] [Abstract][Full Text] [Related]
2. Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition.
Wu J; Echeverry R; Guzman J; Yepes M
Am J Pathol; 2010 Nov; 177(5):2576-84. PubMed ID: 20864675
[TBL] [Abstract][Full Text] [Related]
3. A signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptor-induced neuronal cell death and ischemic brain damage.
Zhang SJ; Buchthal B; Lau D; Hayer S; Dick O; Schwaninger M; Veltkamp R; Zou M; Weiss U; Bading H
J Neurosci; 2011 Mar; 31(13):4978-90. PubMed ID: 21451036
[TBL] [Abstract][Full Text] [Related]
4. 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo.
Liot G; Benchenane K; Léveillé F; López-Atalaya JP; Fernández-Monreal M; Ruocco A; Mackenzie ET; Buisson A; Ali C; Vivien D
J Cereb Blood Flow Metab; 2004 Oct; 24(10):1153-9. PubMed ID: 15529015
[TBL] [Abstract][Full Text] [Related]
5. Tissue-type plasminogen activator mediates neuronal detection and adaptation to metabolic stress.
Wu F; Nicholson AD; Haile WB; Torre E; An J; Chen C; Lee AK; Duong DM; Dammer EB; Seyfried NT; Tong FC; Votaw JR; Yepes M
J Cereb Blood Flow Metab; 2013 Nov; 33(11):1761-9. PubMed ID: 23881246
[TBL] [Abstract][Full Text] [Related]
6. Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.
Lesept F; Chevilley A; Jezequel J; Ladépêche L; Macrez R; Aimable M; Lenoir S; Bertrand T; Rubrecht L; Galea P; Lebouvier L; Petersen KU; Hommet Y; Maubert E; Ali C; Groc L; Vivien D
Cell Death Dis; 2016 Nov; 7(11):e2466. PubMed ID: 27831563
[TBL] [Abstract][Full Text] [Related]
7. Tissue-type plasminogen activator mediates neuroglial coupling in the central nervous system.
An J; Haile WB; Wu F; Torre E; Yepes M
Neuroscience; 2014 Jan; 257():41-8. PubMed ID: 24200922
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus.
Castorina A; D'Amico AG; Scuderi S; Leggio GM; Drago F; D'Agata V
Neuroscience; 2013 Oct; 250():546-56. PubMed ID: 23906635
[TBL] [Abstract][Full Text] [Related]
9. Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α.
Haile WB; Wu J; Echeverry R; Wu F; An J; Yepes M
J Cereb Blood Flow Metab; 2012 Jan; 32(1):57-69. PubMed ID: 21792242
[TBL] [Abstract][Full Text] [Related]
10. Tissue-type plasminogen activator induces synaptic vesicle endocytosis in cerebral cortical neurons.
Yepes M; Wu F; Torre E; Cuellar-Giraldo D; Jia D; Cheng L
Neuroscience; 2016 Apr; 319():69-78. PubMed ID: 26820595
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C.
Liu D; Cheng T; Guo H; Fernández JA; Griffin JH; Song X; Zlokovic BV
Nat Med; 2004 Dec; 10(12):1379-83. PubMed ID: 15516929
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.
Siao CJ; Tsirka SE
J Neurosci; 2002 May; 22(9):3352-8. PubMed ID: 11978811
[TBL] [Abstract][Full Text] [Related]
13. NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity.
Baron A; Montagne A; Cassé F; Launay S; Maubert E; Ali C; Vivien D
Cell Death Differ; 2010 May; 17(5):860-71. PubMed ID: 19911010
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity.
Zhou X; Ding Q; Chen Z; Yun H; Wang H
J Biol Chem; 2013 Aug; 288(33):24151-9. PubMed ID: 23839940
[TBL] [Abstract][Full Text] [Related]
15. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
[TBL] [Abstract][Full Text] [Related]
16. Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity.
Parcq J; Bertrand T; Montagne A; Baron AF; Macrez R; Billard JM; Briens A; Hommet Y; Wu J; Yepes M; Lijnen HR; Dutar P; Anglés-Cano E; Vivien D
Cell Death Differ; 2012 Dec; 19(12):1983-91. PubMed ID: 22743997
[TBL] [Abstract][Full Text] [Related]
17. Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus.
Echeverry R; Wu J; Haile WB; Guzman J; Yepes M
J Clin Invest; 2010 Jun; 120(6):2194-205. PubMed ID: 20440070
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol protects CA1 neurons against focal cerebral ischemic reperfusion-induced damage via the ERK-CREB signaling pathway in rats.
Li Z; Fang F; Wang Y; Wang L
Pharmacol Biochem Behav; 2016; 146-147():21-7. PubMed ID: 27143440
[TBL] [Abstract][Full Text] [Related]
19. Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury.
Siao CJ; Fernandez SR; Tsirka SE
J Neurosci; 2003 Apr; 23(8):3234-42. PubMed ID: 12716930
[TBL] [Abstract][Full Text] [Related]
20. Activity-dependent neuroprotection and cAMP response element-binding protein (CREB): kinase coupling, stimulus intensity, and temporal regulation of CREB phosphorylation at serine 133.
Lee B; Butcher GQ; Hoyt KR; Impey S; Obrietan K
J Neurosci; 2005 Feb; 25(5):1137-48. PubMed ID: 15689550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
